Key Points
- To identify novel molecular targets and clarify the mechanisms underlying the progression from unruptured to ruptured intracranial aneurysms driven by hypertension.
- Integrated GWAS summary statistics for unruptured and ruptured intracranial aneurysms with three transcriptomic datasets (GSE13353, GSE26969, GSE75436) comprising 55 samples (29 cases vs. 26 controls).
- Identified differentially expressed single nucleotide polymorphisms and differentially expressed genes (|logFC| > mean(abs(logFC)) + 2*sd(abs(logFC)), p < 0.05), followed by functional enrichment and protein-protein interaction network construction.
- Constructed a predictive progression model using LASSO regression with an L1 penalty and assessed classification performance via receiver operating characteristic curves.
- Identified 31 hub genes and two consensus shared genes (ITGAX and MAGI2) across all four datasets, alongside key protein interactions ITGAX-JAM3 and KLHL28-TOGARAM1.
- Selected optimal characteristic genes using LASSO regression, with model classification performance validated at AUC > 0.85.
- Identified ITGAX, JAM3, KLHL28, TOGARAM1, and MAGI2 as potential molecular targets mediating hypertension-driven mechano-immune crosstalk during aneurysm rupture progression.
Bioinformatic analysis identified ITGAX, JAM3, KLHL28, TOGARAM1, and MAGI2 as novel potential molecular targets for hypertension-driven intracranial aneurysm rupture progression.
Limitations
- Mechanistic insights are primarily derived from bioinformatic inferences and indirect evidence
- Absence of external validation in an independent dataset
- Limited prior functional annotation and research resources